With Briefly Bio scientists no longer need to reinvent the wheel – spending time and resources on experiments that they can’t reproduce. This will enable scientists to produce datasets that will quickly expand our understanding of biology. London, UK – Science is in a reproducibility crisis. In preclinical research, it’s estimated that over 50% of efforts […]
SAN DIEGO — Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation from FusionX Ventures and Vertical Venture Partners, is complemented by two ongoing SBIR grants totaling $4 million from The National Human Genome Research […]
STOCKHOLM, Sweden – Moleculent AB, a company pioneering technology to study the communication between cells in human tissue, today announced the closing of its oversubscribed $26 million Series A financing. The round was led by ARCH Venture Partners (ARCH) and co-led by Eir Ventures with participation from the company’s existing investors. ARCH’s Patrick Weiss has been […]
Quebec City, Canada – Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin […]
QUEBEC CITY — Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin Leblanc, […]
LOWER GWYNEDD, Pa. — ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce the award of NIH IIB grant of $2M from the National Institute of General Medical Sciences, for the development and integration of ChromaTan’s novel BioRMB™ single-use, column-free, steady-state continuous counter-current elution technology for manufacturing AAVs. This project […]
ATLANTA – Andson Biotech, a biotools company developing streamlined sample prep and data analytics solutions for mass spectrometry workflows, has successfully closed a $3.6 million round in equity financing. This capital will support hiring talent to accelerate the market introduction of its inline mass spec sample prep solution, DynaCHIP. This patented technology seamlessly integrates into existing mass spec […]
We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination. We believe the company holds great promise to expand the use of CryoEM in drug development, with their cloud-based data […]
Financing will fund growth and expansion of new functional single-cell analysis and sorting product lines for drug discovery, enabled by Partillion’s proprietary Nanovial technology. LOS ANGELES – Partillion Bioscience Corporation (“Partillion”), a life science tools company, today announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear […]
Zoic Capital … funds medical technologies with the ability to improve life. ChromaTan’s bioprocessing purification systems will usher in a new lean, agile, and efficient generation of medicine.” – Neal Mody, Zoic Capital SEATTLE, WA, USA — Zoic Capital , a Seattle-based med-tech investment firm, has participated in a new round of funding for ChromaTan . […]
Pay Invoice
Latest Blogs
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
-
Steady Demand in the Industrial Market for Analytical and Scientific Instrumentation
July 30, 2024 3:07 pm
-
The Analytical Instrument Market: Shifting Growth Dynamics
June 27, 2024 2:36 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
